Inhibitory Antibodies
-
F1961 Anti-CXCL4/PF4 Antibody (U.Penn. patent anti-PF4)Summary: Anti-CXCL4/PF4 Antibody (U.Penn. patent anti-PF4) -
F1962 Anti-CXCL8/IL-8 Antibody (Genentech patent anti-IL-8)Summary: Anti-CXCL8/IL-8 Antibody (Genentech patent anti-IL-8) -
F1963 Anti-CXCR3/GPR9/CD183 Antibody (Genzyme patent anti-CXCR3)Summary: Anti-CXCR3/GPR9/CD183 Antibody (Genzyme patent anti-CXCR3) -
F1964 Anti-CXCR4/CD184 Antibody (Dana-Farber patent anti-CXCR4)Summary: Anti-CXCR4/CD184 Antibody (Dana-Farber patent anti-CXCR4) -
F1965 Anti-CXCR4/CD184 Antibody (Ulocuplumab-MMAE)Summary: Anti-CXCR4/CD184 Antibody (Ulocuplumab-MMAE) -
F1966 Anti-CYR61/CCN1 Antibody (Roche patent anti-CCN1)Summary: Anti-CYR61/CCN1 Antibody (Roche patent anti-CCN1) -
F1967 Anti-DCSTAMP Antibody (U.Rochester patent anti-DC-STAMP)Summary: Anti-DCSTAMP Antibody (U.Rochester patent anti-DC-STAMP) -
F1968 Anti-DLL3 Antibody (Dragonfly patent anti-DLL3)Summary: Anti-DLL3 Antibody (Dragonfly patent anti-DLL3) -
F1969 Anti-DLL3 Antibody (Rovalpituzumab-MMAE)Summary: Anti-DLL3 Antibody (Rovalpituzumab-MMAE) -
F1970 Anti-DLL4 Antibody (Smart Targeting patent anti-DLL4)Summary: Anti-DLL4 Antibody (Smart Targeting patent anti-DLL4)